Attending the AASLD Liver Meeting 2019, November 8-12, in Boston? AASLD brings together over 9500 hepatologists and hepatology health professionals across the globe to exchange the latest liver disease research, discuss treatment outcomes, and network.
WuXi AppTec welcomes a chance to connect with you during AASLD. Below please see the many ways you can engage with WuXi AppTec scientists and business development executives.
WuXi scientists are available for consultation while at AASLD. Pre-arrange a private meeting to learn how WuXi AppTec can support your liver disease research program.
Contact us at:
Deming Xu, PhD, Executive Director, RSD (email@example.com)
Declan Ryan, PhD, VP of Business Development, RSD (firstname.lastname@example.org)
Yu Chen, Director, Business Development, RSD (email@example.com)
Mahnaz Arjomand, Director, Business Development, RSD (Mahnaz_arjomand@wuxiapptec.com)
We look forward to seeing you in Boston!
The WuXi AppTec Research Service Division (RSD) offers comprehensive R&D services and clinical support for liver disease research, including a full array of HBV services from assay establishment and validation, compound screening and profiling, MOA studies, and support from discovery through clinical trial. Further, our Center of Excellence for NASH offers NASH related in vitro and in vivo pharmacology services, and conducts discovery research on NASH pathophysiology, biomarkers and mechanistic pharmacology of NASH and new therapeutic targets.